Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection

Stem Cells and Development

Volumn 23, Issue 9, 2014, Pages 978-989

  Guo, Ling ^a   Ge, Jianfeng ^a   Zhou, Ying ^a   Wang, Shan ^a   Zhao, Robert C H ^b   Wu, Yaojiong ^a  

^a TSINGHUA UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL OCCLUSION; BRAIN EMBOLISM; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; MULTICELLULAR SPHEROID; SPRAGUE DAWLEY RAT; STROKE; TRANSPLANTATION; XENOGRAFT;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HETEROGRAFTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SPHEROIDS, CELLULAR; STROKE;

EID: 84899076897     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0338     Document Type: Article

References (38)

1. Hacke W, M Kaste, E Bluhmki, M Brozman, A Davalos, D Guidetti, V Larrue, KR Lees, Z Medeghri, et al. (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317-1329.
2. Zhang ZG and M Chopp. (2009). Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8:491-500.
3. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
4. Horwitz EM. (2006). MSC: a coming of age in regenerative medicine. Cytotherapy 8:194-195.
5. Wu Y, L Chen, PG Scott and EE Tredget. (2007). Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25:2648-2659.
6. Chamberlain G, J Fox, B Ashton and J Middleton. (2007). Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749.
7. Keating A. (2012). Mesenchymal stromal cells: new directions. Cell Stem Cell 10:709-716.
8. Salem HK and C Thiemermann. (2010). Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28:585-596.
9. Chen J, Y Li, L Wang, Z Zhang, D Lu, M Lu and M Chopp. (2001). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005-1011.
10. Mangi AA, N Noiseux, D Kong, H He, M Rezvani, JS Ingwall and VJ Dzau. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201.
11. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736.
12. Li Z, C Liu, Z Xie, P Song, RC Zhao, L Guo, Z Liu and Y Wu. (2011). Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One 6:e20526.
13. Wu Y, RC Zhao and EE Tredget. (2010). Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells 28:905-915.
14. Potapova IA, GR Gaudette, PR Brink, RB Robinson, MR Rosen, IS Cohen and SV Doronin. (2007). Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 25:1761-1768.
15. Wu Y and RC Zhao. (2012). The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev 8:243-250.
16. Lee RH, AA Pulin, MJ Seo, DJ Kota, J Ylostalo, BL Larson, L Semprun-Prieto, P Delafontaine and DJ Prockop. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63.
17. Toma C, WR Wagner, S Bowry, A Schwartz and F Villanueva. (2009). Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res 104:398-402.
18. Bartosh TJ, JH Ylostalo, A Mohammadipoor, N Bazhanov, K Coble, K Claypool, RH Lee, H Choi and DJ Prockop. (2010). Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A 107:13724-13729.
19. Longa EZ, PR Weinstein, S Carlson and R Cummins. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
20. Li Y, J Chen, L Wang, M Lu and M Chopp. (2001). Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56:1666-1672.
21. Powner MB, K Vevis, JA McKenzie, P Gandhi, S Jadeja and M Fruttiger. (2012). Visualization of gene expression in whole mouse retina by in situ hybridization. Nat Protoc 7:1086-1096.
22. Stevens WD, T Fortin and BA Pappas. (2002). Retinal and optic nerve degeneration after chronic carotid ligation: time course and role of light exposure. Stroke 33:1107-1112.
23. Honmou O, R Onodera, M Sasaki, SG Waxman and JD Kocsis. (2012). Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med 18:292-297.
24. Gutierrez-Fernandez M, B Rodriguez-Frutos, J Ramos-Cejudo, M Teresa Vallejo-Cremades, B Fuentes, S Cerdan and E Diez-Tejedor. (2013). Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther 4:11.
25. Potapova IA, PR Brink, IS Cohen and SV Doronin. (2008). Culturing of human mesenchymal stem cells as threedimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem 283:13100-13107.
26. Tropel P, N Platet, JC Platel, D Noel, M Albrieux, AL Benabid and F Berger. (2006). Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells 24:2868-2876.
27. Quinn C and AW Flake. (2008). In vivo differentiation potential of mesenchymal stem cells: prenatal and postnatal model systems. Transfus Med Hemother 35:239-247.
28. Cheng NC, S Wang and TH Young. (2012). The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities. Biomaterials 33:1748-1758.
29. Garcia AD, NB Doan, T Imura, TG Bush and MV Sofroniew. (2004). GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci 7:1233-1241.
30. Miller FD and A Gauthier-Fisher. (2009). Home at last: neural stem cell niches defined. Cell Stem Cell 4:507-510.
31. Buffo A, I Rite, P Tripathi, A Lepier, D Colak, AP Horn, T Mori and M Gotz. (2008). Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc Natl Acad Sci U S A 105:3581-3586.
32. Sanai N, AD Tramontin, A Quinones-Hinojosa, NM Barbaro, N Gupta, S Kunwar, MT Lawton, MW McDermott, AT Parsa, et al. (2004). Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427:740-744.
33. Arvidsson A, T Collin, D Kirik, Z Kokaia and O Lindvall. (2002). Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8:963-970.
34. Leu S, YC Lin, CM Yuen, CH Yen, YH Kao, CK Sun and HK Yip. (2010). Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med 8:63-79.
35. Honma T, O Honmou, S Iihoshi, K Harada, K Houkin, H Hamada and JD Kocsis. (2006). Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 199:56-66.
36. Vulliet PR, M Greeley, SM Halloran, KA MacDonald and MD Kittleson. (2004). Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363:783-784.
37. Freyman T, G Polin, H Osman, J Crary, M Lu, L Cheng, M Palasis and RL Wilensky. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:1114-1122.
38. Janowski M, A Lyczek, C Engels, J Xu, B Lukomska, JW Bulte and P Walczak. (2013). Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab 33:921-927.